-
1
-
-
45149089132
-
Hodgkin's lymphoma: ESMO clinical recommendations for diagnosis, treatment and follow-up
-
suppl 2
-
Engert A, Dreyling M: Hodgkin's lymphoma: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 19:ii65-ii66, 2008 (suppl 2)
-
(2008)
Ann Oncol
, vol.19
-
-
Engert, A.1
Dreyling, M.2
-
2
-
-
33750837637
-
Combined modality treatment of two or four cycles of ABVD followed by involved field radiotherapy in the treatment of patients with early stage Hodgkin's lymphoma: Update interim analysis of the randomised HD10 study of the German Hodgkin Study Group (GHSG)
-
abstr
-
Engert A, Pluetschow A, Eich HT, et al: Combined modality treatment of two or four cycles of ABVD followed by involved field radiotherapy in the treatment of patients with early stage Hodgkin's lymphoma: Update interim analysis of the randomised HD10 study of the German Hodgkin Study Group (GHSG). Blood 106:2673a, 2005 (abstr)
-
(2005)
Blood
, vol.106
-
-
Engert, A.1
Pluetschow, A.2
Eich, H.T.3
-
3
-
-
35848959692
-
Chemotherapy plus involved-field radiation in earlystage Hodgkin's disease
-
Fermé C, Eghbali H, Meerwaldt JH, et al: Chemotherapy plus involved-field radiation in earlystage Hodgkin's disease. N Engl J Med 357:1916-1927, 2007
-
(2007)
N Engl J Med
, vol.357
, pp. 1916-1927
-
-
Fermé, C.1
Eghbali, H.2
Meerwaldt, J.H.3
-
4
-
-
0141939066
-
Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with earlystage unfavorable Hodgkin's lymphoma: Results of the HD8 trial of the German Hodgkin's Lymphoma Study Group
-
Engert A, Schiller P, Josting A, et al: Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with earlystage unfavorable Hodgkin's lymphoma: Results of the HD8 trial of the German Hodgkin's Lymphoma Study Group. J Clin Oncol 21:3601-3608, 2003
-
(2003)
J Clin Oncol
, vol.21
, pp. 3601-3608
-
-
Engert, A.1
Schiller, P.2
Josting, A.3
-
5
-
-
24944453433
-
Comparison of BEACOPP and ABVD chemotherapy in intermediate stage Hodgkin's lymphoma: Results of the fourth interim analysis of the HD 11 trial of the GHSG
-
suppl 16S; abstr 6507, 561s
-
Klimm B, Engert A, Brillant C, et al: Comparison of BEACOPP and ABVD chemotherapy in intermediate stage Hodgkin's lymphoma: Results of the fourth interim analysis of the HD 11 trial of the GHSG. J Clin Oncol 23:561s, 2005 (suppl 16S; abstr 6507)
-
(2005)
J Clin Oncol
, vol.23
-
-
Klimm, B.1
Engert, A.2
Brillant, C.3
-
6
-
-
0026439199
-
Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD
-
Canellos GP, Anderson JR, Propert KJ, et al: Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD. N Engl J Med 327:1478-1484, 1992
-
(1992)
N Engl J Med
, vol.327
, pp. 1478-1484
-
-
Canellos, G.P.1
Anderson, J.R.2
Propert, K.J.3
-
7
-
-
0037567428
-
Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease
-
Diehl V, Franklin J, Pfreundschuh M, et al: Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease. N Engl J Med 348:2386-2395,2003
-
(2003)
N Engl J Med
, vol.348
, pp. 2386-2395
-
-
Diehl, V.1
Franklin, J.2
Pfreundschuh, M.3
-
8
-
-
0344771027
-
High cure rates and reduced long-term toxicity in pediatric Hodgkin's disease: The German-Austrian multicenter trial DAL-HD-90-The German-Austrian Pediatric Hodgkin's Disease Study Group
-
Schellong G, Potter R, Bramswig J, et al: High cure rates and reduced long-term toxicity in pediatric Hodgkin's disease: The German-Austrian multicenter trial DAL-HD-90-The German-Austrian Pediatric Hodgkin's Disease Study Group. J Clin Oncol 17:3736-3744, 1999
-
(1999)
J Clin Oncol
, vol.17
, pp. 3736-3744
-
-
Schellong, G.1
Potter, R.2
Bramswig, J.3
-
9
-
-
16544364620
-
Riskadapted, combined-modality therapy with VAMP/ COP and response-based, involved-field radiation for unfavorable pediatric Hodgkin's disease
-
Hudson MM, Krasin M, Link MP, et al: Riskadapted, combined-modality therapy with VAMP/ COP and response-based, involved-field radiation for unfavorable pediatric Hodgkin's disease. J Clin Oncol 22:4541-4550, 2004
-
(2004)
J Clin Oncol
, vol.22
, pp. 4541-4550
-
-
Hudson, M.M.1
Krasin, M.2
Link, M.P.3
-
10
-
-
33846903567
-
Final results of a prospective clinical trial with VAMP and low-dose involved-field radiation for children with low-risk Hodgkin's disease
-
Donaldson SS, Link MP, Weinstein HJ, et al: Final results of a prospective clinical trial with VAMP and low-dose involved-field radiation for children with low-risk Hodgkin's disease. J Clin Oncol 25: 332-337, 2007
-
(2007)
J Clin Oncol
, vol.25
, pp. 332-337
-
-
Donaldson, S.S.1
Link, M.P.2
Weinstein, H.J.3
-
11
-
-
0038459195
-
Preliminary results of the multicenter trial GPOH-HD 95 for the treatment of Hodgkin's disease in children and adolescents: Analysis and outlook
-
Dörffel W, Luders H, Ruhl U, et al: Preliminary results of the multicenter trial GPOH-HD 95 for the treatment of Hodgkin's disease in children and adolescents: Analysis and outlook. Klin Padiatr 215: 139-145, 2003
-
(2003)
Klin Padiatr
, vol.215
, pp. 139-145
-
-
Dörffel, W.1
Luders, H.2
Ruhl, U.3
-
12
-
-
10744222812
-
Importance of F18-fluorodeoxy-D-2-glucose positron emission tomography (FDG-PET) for staging and therapy control of Hodgkin's lymphoma in childhood and adolescence: Consequences for the GPOH-HD 2003 protocol
-
Körholz D, Kluge R, Wickmann L, et al: Importance of F18-fluorodeoxy-D-2-glucose positron emission tomography (FDG-PET) for staging and therapy control of Hodgkin's lymphoma in childhood and adolescence: Consequences for the GPOH-HD 2003 protocol. Onkologie 26:489-493, 2003
-
(2003)
Onkologie
, vol.26
, pp. 489-493
-
-
Körholz, D.1
Kluge, R.2
Wickmann, L.3
-
13
-
-
34247379458
-
Adolescents with Hodgkin lymphoma treated on adult and pediatric protocols have distinct therapeutic outcome
-
abstr
-
Mottl AA, Fisher SG, Fisher RI, et al: Adolescents with Hodgkin lymphoma treated on adult and pediatric protocols have distinct therapeutic outcome. Blood 104:312, 2004 (abstr)
-
(2004)
Blood
, vol.104
, pp. 312
-
-
Mottl, A.A.1
Fisher, S.G.2
Fisher, R.I.3
-
14
-
-
0032548107
-
A prognostic score for advanced Hodgkin's disease: International Prognostic Factors Project on Advanced Hodgkin's Disease
-
Hasenclever D, Diehl V: A prognostic score for advanced Hodgkin's disease: International Prognostic Factors Project on Advanced Hodgkin's Disease. N Engl J Med 339:1506-1514, 1998
-
(1998)
N Engl J Med
, vol.339
, pp. 1506-1514
-
-
Hasenclever, D.1
Diehl, V.2
-
15
-
-
0037080280
-
Rapidly alternating COPP/ABV/IMEP is not superior to conventional alternating COPP/ABVD in combination with extended-field radiotherapy in intermediatestage Hodgkin's lymphoma: Final results of the German Hodgkin's Lymphoma Study Group Trial HD5
-
Sieber M, Tesch H, Pfistner B, et al: Rapidly alternating COPP/ABV/IMEP is not superior to conventional alternating COPP/ABVD in combination with extended-field radiotherapy in intermediatestage Hodgkin's lymphoma: Final results of the German Hodgkin's Lymphoma Study Group Trial HD5. J Clin Oncol 20:476-484, 2002
-
(2002)
J Clin Oncol
, vol.20
, pp. 476-484
-
-
Sieber, M.1
Tesch, H.2
Pfistner, B.3
-
16
-
-
8044250873
-
BEACOPP: An intensified chemotherapy regimen in advanced Hodgkin's disease-The German Hodgkin's Lymphoma Study Group
-
Diehl V, Sieber M, Ruffer U, et al: BEACOPP: An intensified chemotherapy regimen in advanced Hodgkin's disease-The German Hodgkin's Lymphoma Study Group. Ann Oncol 8:143-148, 1997
-
(1997)
Ann Oncol
, vol.8
, pp. 143-148
-
-
Diehl, V.1
Sieber, M.2
Ruffer, U.3
-
17
-
-
0035367817
-
Low-dose radiation is sufficient for the noninvolved extended-field treatment in favorable early-stage Hodgkin's disease: Long-term results of a randomized trial of radiotherapy alone
-
Dühmke E, Franklin J, Pfreundschuh M, et al: Low-dose radiation is sufficient for the noninvolved extended-field treatment in favorable early-stage Hodgkin's disease: Long-term results of a randomized trial of radiotherapy alone. J Clin Oncol 19:2905-2914, 2001
-
(2001)
J Clin Oncol
, vol.19
, pp. 2905-2914
-
-
Dühmke, E.1
Franklin, J.2
Pfreundschuh, M.3
-
18
-
-
34548186696
-
Two cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine plus extended-field radiotherapy is superior to radiotherapy alone in early favorable Hodgkin's lymphoma: Final results of the GHSG HD7 trial
-
Engert A, Franklin J, Eich HT, et al: Two cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine plus extended-field radiotherapy is superior to radiotherapy alone in early favorable Hodgkin's lymphoma: Final results of the GHSG HD7 trial. J Clin Oncol 25:3495-3502, 2007
-
(2007)
J Clin Oncol
, vol.25
, pp. 3495-3502
-
-
Engert, A.1
Franklin, J.2
Eich, H.T.3
-
19
-
-
10744224542
-
Treatment of advanced Hodgkin's disease with COPP/ ABV/IMEP versus COPP/ABVD and consolidating radiotherapy: Final results of the German Hodgkin's Lymphoma Study Group HD6 trial
-
Sieber M, Tesch H, Pfistner B, et al: Treatment of advanced Hodgkin's disease with COPP/ ABV/IMEP versus COPP/ABVD and consolidating radiotherapy: Final results of the German Hodgkin's Lymphoma Study Group HD6 trial. Ann Oncol 15: 276-282, 2004
-
(2004)
Ann Oncol
, vol.15
, pp. 276-282
-
-
Sieber, M.1
Tesch, H.2
Pfistner, B.3
-
20
-
-
84871466804
-
-
Statistisches Bundesamt Deutschland
-
Statistisches Bundesamt Deutschland: Tables [inGerman].http://www. destatis.de/jetspeed/portal/cms/Sites/destatis/Internet/DE/Navigation/ Statistiken/Bevoelkerung/GeburtenSterbefaelle/Tabellen.psml
-
Tables [inGerman]
-
-
-
21
-
-
84871466037
-
-
Glasmacher S: Cancer in Germany 2003-2004: Frequency and trends [in German]. http://idwonline.de/pages/de/news?print=1&id=247547
-
Glasmacher S: Cancer in Germany 2003-2004: Frequency and trends [in German]. http://idwonline.de/pages/de/news?print=1&id=247547
-
-
-
-
23
-
-
0028003711
-
Hodgkin's disease in children in the West Midlands, 1957-1986: A large population-based study
-
Parkes SE, Coad NA, Muir KR, et al: Hodgkin's disease in children in the West Midlands, 1957-1986: A large population-based study. Pediatr Hematol Oncol 11:471-486, 1994
-
(1994)
Pediatr Hematol Oncol
, vol.11
, pp. 471-486
-
-
Parkes, S.E.1
Coad, N.A.2
Muir, K.R.3
-
25
-
-
3042731977
-
Long term outcome in adolescents with Hodgkin's lymphoma: Poor results using regimens designed for adults
-
Yung L, Smith P, Hancock BW, et al: Long term outcome in adolescents with Hodgkin's lymphoma: Poor results using regimens designed for adults. Leuk Lymphoma 45:1579-1585, 2004
-
(2004)
Leuk Lymphoma
, vol.45
, pp. 1579-1585
-
-
Yung, L.1
Smith, P.2
Hancock, B.W.3
-
26
-
-
51049095165
-
Poor outcome in adolescents with high-risk Hodgkin lymphoma
-
Herbertson RA, Evans LS, Hutchinson J, et al: Poor outcome in adolescents with high-risk Hodgkin lymphoma. Int J Oncol 33:145-151, 2008
-
(2008)
Int J Oncol
, vol.33
, pp. 145-151
-
-
Herbertson, R.A.1
Evans, L.S.2
Hutchinson, J.3
-
27
-
-
0033952110
-
Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood
-
van Leeuwen FE, Klokman WJ, Veer MB, et al: Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood. J Clin Oncol 18:487-497, 2000
-
(2000)
J Clin Oncol
, vol.18
, pp. 487-497
-
-
van Leeuwen, F.E.1
Klokman, W.J.2
Veer, M.B.3
-
28
-
-
0037102360
-
Second malignant neoplasms among long-term survivors of Hodgkin's disease: A population-based evaluation over 25 years
-
Dores GM, Metayer C, Curtis RE, et al: Second malignant neoplasms among long-term survivors of Hodgkin's disease: A population-based evaluation over 25 years. J Clin Oncol 20:3484-3494, 2002
-
(2002)
J Clin Oncol
, vol.20
, pp. 3484-3494
-
-
Dores, G.M.1
Metayer, C.2
Curtis, R.E.3
-
29
-
-
0142058040
-
Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin's disease: A report from the German Hodgkin's Lymphoma Study Group
-
Josting A, Wiedenmann S, Franklin J, et al: Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin's disease: A report from the German Hodgkin's Lymphoma Study Group. J Clin Oncol 21:3440-3446, 2003
-
(2003)
J Clin Oncol
, vol.21
, pp. 3440-3446
-
-
Josting, A.1
Wiedenmann, S.2
Franklin, J.3
-
30
-
-
0035300679
-
Non-Hodgkin's lymphoma after primary Hodgkin's disease in the German Hodgkin's Lymphoma Study Group: Incidence, treatment, and prognosis
-
Rueffer U, Josting A, Franklin J, et al: Non-Hodgkin's lymphoma after primary Hodgkin's disease in the German Hodgkin's Lymphoma Study Group: Incidence, treatment, and prognosis. J Clin Oncol 19:2026-2032, 2001
-
(2001)
J Clin Oncol
, vol.19
, pp. 2026-2032
-
-
Rueffer, U.1
Josting, A.2
Franklin, J.3
-
31
-
-
32144439729
-
Acute myeloid leukemia following Hodgkin lymphoma: A population-based study of 35,511 patients
-
Schonfeld SJ, Gilbert ES, Dores GM, et al: Acute myeloid leukemia following Hodgkin lymphoma: A population-based study of 35,511 patients. J Natl Cancer Inst 98:215-218, 2006
-
(2006)
J Natl Cancer Inst
, vol.98
, pp. 215-218
-
-
Schonfeld, S.J.1
Gilbert, E.S.2
Dores, G.M.3
|